Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action

Despite the validation of direct-acting antivirals for hepatitis C treatment, the discovery of new compounds with different modes of action may still be of importance for the treatment of special patient populations. We recently identified a natural molecule, epigallocatechin-3-gallate (EGCG), as an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Virol
Autors principals: Calland, Noémie, Sahuc, Marie-Emmanuelle, Belouzard, Sandrine, Pène, Véronique, Bonnafous, Pierre, Mesalam, Ahmed Atef, Deloison, Gaspard, Descamps, Véronique, Sahpaz, Sevser, Wychowski, Czeslaw, Lambert, Olivier, Brodin, Priscille, Duverlie, Gilles, Meuleman, Philip, Rosenberg, Arielle R., Dubuisson, Jean, Rouillé, Yves, Séron, Karin
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2015
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4577911/
https://ncbi.nlm.nih.gov/pubmed/26202241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01473-15
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars